Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 153, Issue 8, 2010, Pages 1448-1458

  Winterer, Georg ^a,b   Mittelstrass, Kirstin ^c   Giegling, Ina ^d   Lamina, Claudia ^c,e   Fehr, Christoph ^f   Brenner, Hermann ^g   Breitling, Lutz P ^g   Nitz, Barbara ^c   Raum, Elke ^g   Müller, Heiko ^g   Gallinat, Jürgen ^h   Gal, Andreas ⁱ   Heim, Katharina ^j   Prokisch, Holger ^j   Meitinger, Thomas ^j   Hartmann, Annette M ^k   Möller, Hans Jürgen ^k   Gieger, Christian ^c   Wichmann, H Erich ^c   Illig, Thomas ^c   Dahmen, Norbert ^f   Rujescu, Dan ^k   more..

^a UNIVERSITY OF COLOGNE   (Germany)

^b Helmholtz Center Juelich   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^e INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^f JOHANNES GUTENBERG UNIVERSITY   (Germany)

^g GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^h CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

ⁱ UNIVERSITY OF HAMBURG   (Germany)

^j TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^k UNIVERSITY OF MUNICH   (Germany)

more..

Author keywords

CHRNA5 CHRNA3 CHRNB4; Cognition; Gene expression; N back task; Nicotine dependence; Single nucleotide polymorphisms

Indexed keywords

NICOTINE;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CHRNA3 GENE; CHRNA5 GENE; CHRNB4 GENE; COGNITION; FEMALE; GENE; GENE CLUSTER; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TASK PERFORMANCE; TOBACCO DEPENDENCE; WECHSLER INTELLIGENCE SCALE;

ADULT; AGED; CHROMOSOMES, HUMAN, PAIR 15; COGNITION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MULTIGENE FAMILY; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, NICOTINIC; RISK; RNA, MESSENGER; TOBACCO USE DISORDER; WECHSLER SCALES;

EID: 78851471766     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31126     Document Type: Article

References (64)

1. Agrawal A, Lynskey MT. 2008. Are there genetic influences on addiction: Evidence from family, adoption and twin studies. Addiction 103: 1069-1081.
2. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, Dong Q, Zhang Q, Gu X, Vijayakrishnan J, Sullivan K, Matakidou A, Wang Y, Mills G, Doheny K, Tsai YY, Chen WV, Shete S, Spitz MR, Houlston RS. 2008. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 40: 616-622.
3. Batra V, Patkar AA, Berrettini WH, Weinstein SP, Leone FT. 2003. The genetic determinants of smoking. Chest 123: 1730-1739.
4. Batty GD, Deary IJ, Macintyre S. 2007a. Childhood IQ in relation to risk factors for premature mortality in middle-aged persons: The Aberdeen Children of the 1950s study. J Epidemiol Community Health 61: 241-247.
5. Batty GD, Wennerstad KM, Smith GD, Gunnell D, Deary IJ, Tynelius P, Rasmussen F. 2007b. IQ in early adulthood and later cancer risk: Cohort study of one million Swedish men. Ann Oncol 18: 21-28.
6. Benowitz NL. 2008. Clinical pharmacology of nicotine: Implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther 83: 531-541.
7. Berrettini W, Yuan X, Tozzi F, Song K, Francks C, Chilcoat H, Waterworth D, Muglia P, Mooser V. 2008. Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Mol Psychiatry 13: 368-373.
8. Bierut LJ, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau OF, Swan GE, Rutter J, Bertelsen S, Fox L, Fugman D, Goate AM, Hinrichs AL, Konvicka K, Martin NG, Montgomery GW, Saccone NL, Saccone SF, Wang JC, Chase GA, Rice JP, Ballinger DG. 2007. Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet 16: 24-35.
9. Bierut LJ, Stitzel JA, Wang JC, Hinrichs AL, Grucza RA, Xuei X, Saccone NL, Saccone SF, Bertelsen S, Fox L, Horton WJ, Breslau N, Budde J, Cloninger CR, Dick DM, Foroud T, Hatsukami D, Hesselbrock V, Johnson EO, Kramer J, Kuperman S, Madden PA, Mayo K, Nurnberger J, Jr., Pomerleau O, Porjesz B, Reyes O, Schuckit M, Swan G, Tischfield JA, Edenberg HJ, Rice JP, Goate AM. 2008. Variants in nicotinic receptors and risk for nicotine dependence. Am J Psychiatry 165: 1163-1171.
10. Bouchard TJ, Jr. 1998. Genetic and environmental influences on adult intelligence and special mental abilities. Hum Biol 70: 257-279.
11. Breitling LP, Dahmen N, Mittelstrass K, Illig T, Rujescu D, Raum E, Winterer G, Brenner H. 2009. Smoking cessation and variations in nicotinic acetylcholine receptor subunits alpha-5, alpha-3, and beta-4 genes. Biol Psychiatry 65: 691-695.
12. Brinkmeyer J, Mobascher A, Musso F, Schmitz M, Wagner M, Gründer G, Spreckelmeyer KN, Wienker T, Diaz-Lacava A, Holler D, Dahmen N, Thuerauf N, Clepce M, Kiefer F, de Millas W, Gallinat J, Winterer G. P50 sensory gating and smoking in the general population. Addiction Biol. (accepted).
13. Comings DE, Wu S, Rostamkhani M, McGue M, Lacono WG, Cheng LS, MacMurray JP. 2003. Role of the cholinergic muscarinic 2 receptor (CHRM2) gene in cognition. Mol Psychiatry 8: 10-11.
14. Deary IJ, Whalley LJ, Starr J. 2003. IQ at age 11 and longevity: Results from a follow-up of the Scottish Mental Survey 1932. In: Christen Y, editor. Brain and longevity: Perspectives in longevity. Berlin: Springer, 153-164.
15. Deary IJ, Johnson W, Houlihan LM. 2009. Genetic foundations of human intelligence. Hum Genet 126: 215-232.
16. Doran N, Cook J, McChargue D, Spring B. 2009. Impulsivity and cigarette craving: Differences across subtypes. Psychopharmacol (Berl) 207: 365-373.
17. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR. 2001. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98: 6917-6922.
18. Ernst M, Matochik JA, Heishman SJ, Van Horn JD, Jons PH, Henningfield JE, London ED. 2001a. Effect of nicotine on brain activation during performance of a working memory task. Proc Natl Acad Sci USA 98: 4728-4733.
19. Ernst M, Heishman SJ, Spurgeon L, London ED. 2001b. Smoking history and nicotine effects on cognitive performance. Neuropsychopharmacology 25: 313-319.
20. Espeseth T, Greenwood PM, Reinvang I, Fjell AM, Walhovd KB, Westlye LT, Wehling E, Lundervold A, Rootwelt H, Parasuraman R. 2006. Interactive effects of APOE and CHRNA4 on attention and white matter volume in healthy middle-aged and older adults. Cogn Affect Behav Neurosci 6: 31-43.
21. Fergusson DM, Horwood LJ, Ridder EM. 2005. Show me the child at seven II: Childhood intelligence and later outcomes in adolescence and young adulthood. J Child Psychol Psychiatry 46: 850-858.
22. Ferrea S, Winterer G. 2009. Neuroprotective and neurotoxic effects of nicotine. Pharmacopsychiatry 42: 255-265.
23. Fried PA, Watkinson B, Gray R. 2006. Neurocognitive consequences of cigarette smoking in young adults-a comparison with pre-drug performance. Neurotoxicol Teratol 28: 517-525.
24. Gallinat J, Bajbouj M, Sander T, Schlattmann P, Xu K, Ferro EF, Goldman D, Winterer G. 2003. Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing. Biol Psychiatry 54: 40-48.
25. Gehricke JG, Loughlin SE, Whalen CK, Potkin SG, Fallon JH, Jamner LD, Belluzzi JD, Leslie FM. 2007. Smoking to self-medicate attentional and emotional dysfunctions. Nicotine Tob Res 9(Suppl. 4): 523-536.
26. Gosso MF, van Belzen M, de Geus EJ, Polderman JC, Heutink P, Boomsma DI, Posthuma D. 2006. Association between the CHRM2 gene and intelligence in a sample of 304 Dutch families. Genes Brain Behav 5: 577-584.
27. Hemmingsson T, Melin B, Allebeck P, Lundberg I. 2006. The association between cognitive ability measured at ages 18-20 and mortality during 30 years of followup-A prospective observational study among Swedish males born 1949-51. Int J Epidemiol 35: 665-670.
28. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, Lissowska J, Rudnai P, Fabianova E, Mates D, Bencko V, Foretova L, Janout V, Chen C, Goodman G, Field JK, Liloglou T, Xinarianos G, Cassidy A, McLaughlin J, Liu G, Narod S, Krokan HE, Skorpen F, Elvestad MB, Hveem K, Vatten L, Linseisen J, Clavel-Chapelon F, Vineis P, Bueno-de-Mesquita HB, Lund E, Martinez C, Bingham S, Rasmuson T, Hainaut P, Riboli E, Ahrens W, Benhamou S, Lagiou P, Trichopoulos D, Holcátová I, Merletti F, Kjaerheim K, Agudo A, Macfarlane G, Talamini R, Simonato L, Lowry R, Conway DI, Znaor A, Healy C, Zelenika D, Boland A, Delepine M, Foglio M, Lechner D, Matsuda F, Blanche H, Gut I, Heath S, Lathrop M, Brennan P. 2008. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452: 633-637.
29. Khuder SA, Price JH, Jordan T, Khuder SS, Silvestri K. 2008. Cigarette smoking among adolescents in Northwest Ohio: Correlates of prevalence and age at onset. Int J Environ Res Public Health 5: 278-289.
30. Kollins SH, McClernon FJ, Fuemmeler BF. 2005. Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. Arch Gen Psychiatry 62: 1142-1147.
31. Krishnan-Sarin S, Reynolds B, Duhig AM, Smith A, Liss T, McFetridge A, Cavallo DA, Carroll KM, Potenza MN. 2007. Behavioral impulsivity predicts treatment outcome in a smoking cessation program for adolescent smokers. Drug Alcohol Depend 88: 79-82.
32. Kumari V, Gray JA, Ffytche DH, Mitterschiffthaler MT, Das M, Zachariah E, Vythelingum GN, Williams SC, Simmons A, Sharma T. 2003. Cognitive effects of nicotine in humans: An fMRI study. Neuroimage 19: 1002-1013.
33. Lessov-Schlaggar CN, Pergadia ML, Khroyan TV, Swan GE. 2008. Genetics of nicotine dependence and pharmacotherapy. Biochem Pharmacol 75: 178-195.
34. Lindenberg A, Brinkmeyer J, Dahmen N, Gallinat J, de Millas W, Mobascher A, Wagner M, Gründer G, Spreckelmeyer KN, Clepce M, Thürauf N, Kiefer F, Diaz-Lacava A, Steffens M, Wienker T, Winterer G. Submitted. The German Multicenter Study on Nicotine Dependence-Description of a population-based case-control study.
35. Liu JZ, Tozzi F, Waterworth DM, Pillai SG, Muglia P, Middleton L, Berrettini W, Knouff CW, Yuan X, Waeber G, Vollenweider P, Preisig M, Wareham NJ, Zhao JH, Loos RJ, Barroso I, Khaw KT, Grundy S, Barter P, Mahley R, Kesaniemi A, McPherson R, Vincent JB, Strauss J, Kennedy JL, Farmer A, McGuffin P, Day R, Matthews K, Bakke P, Gulsvik A, Lucae S, Ising M, Brueckl T, Horstmann S, Wichmann HE, Rawal R, Dahmen N, Lamina C, Polasek O, Zgaga L, Huffman J, Campbell S, Kooner J, Chambers JC, Burnett MS, Devaney JM, Pichard AD, Kent KM, Satler L, Lindsay JM, Waksman R, Epstein S, Wilson JF, Wild SH, Campbell H, Vitart V, Reilly MP, Li M, Qu L, Wilensky R, Matthai W, Hakonarson HH, Rader DJ, Franke A, Wittig M, Schäfer A, Uda M, Terracciano A, Xiao X, Busonero F, Scheet P, Schlessinger D, St Clair D, Rujescu D, Abecasis GR, Grabe HJ, Teumer A, Völzke H, Petersmann A, John U, Rudan I, Hayward C, Wright AF, Kolcic I, Wright BJ, Thompson JR, Balmforth AJ, Hall AS, Samani NJ, Anderson CA, Ahmad T, Mathew CG, Parkes M, Satsangi J, Caulfield M, Munroe PB, Farrall M, Dominiczak A, Worthington J, Thomson W, Eyre S, Barton A, Wellcome Trust Case Control Consortium, Mooser V, Francks C, Marchini J, 2010. Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nature Genet 42: 436-440.
36. Mobascher A, Winterer G. 2008. The molecular and cellular neurobiology of nicotine abuse in schizophrenia. Pharmacopsychiatry 41(Suppl. 1): 51-59.
37. Mobascher A, Brinkmeyer J, Warbrick T, Wels C, Wagner M, Gründer G, Spreckelmeyer KN, Wienker T, Diaz Lacava A, Dahmen N, Böttcher M, Thuerauf N, Clepce M, Kiefer F, De Millas W, Gallinat J, Winterer G. 2010. The P300 event-related potential and smoking-A population-based case-control study. Int J Psychophysiol 77(2): 166-175.
38. Neuhaus A, Bajbouj M, Kienast T, Kalus P, von Haebler D, Winterer G, Gallinat J. 2006. Persistent dysfunctional frontal lobe activation in former smokers. Psychopharmacol (Berl) 186: 191-200.
39. Newhouse PA, Potter A, Singh A. 2004. Effects of nicotinic stimulation on cognitive performance. Curr Opin Pharmacol 4: 36-46.
40. O'Loughlin J, Karp I, Koulis T, Paradis G, Difranza J. 2009. Determinants of first puff and daily cigarette smoking in adolescents. Am J Epidemiol 170: 585-597.
41. Rezvani AH, Levin ED. 2001. Cognitive effects of nicotine. Biol Psychiatry 49: 258-267.
42. Rigbi A, Kanyas K, Yakir A, Pollak Y, Ben-Asher E, Lancet D, Kertzman S, Lerer B. 2008. Why do young women smoke? V. Role of direct and interactive effects of nicotinic cholinergic receptor gene variation on neurocognitive function. Genes Brain Behav 7: 164-172.
43. Rigbi A, Yakir A, Sarner-Kanyas K, Pollak Y, Lerer B. 2010. Why do young women smoke? VI. A controlled study of nicotine effects on attention: pharmacogenetic interactions. Pharmacogenomics J [Epub ahead of print].
44. Rujescu D, Meisenzahl EM, Giegling I, Kirner A, Leinsinger G, Hegerl U, Hahn K, Möller HJ. 2002. Methionine homozygosity at codon 129 in the prion protein is associated with white matter reduction and enlargement of CSF compartments in healthy volunteers and schizophrenic patients. Neuroimage 15: 200-206.
45. Rujescu D, Hartmann AM, Gonnermann C, Möller HJ, Giegling I. 2003. M129V variation in the prion protein may influence cognitive performance. Mol Psychiatry 8: 937-941.
46. Saccone SF, Hinrichs AL, Saccone NL, Chase GA, Konvicka K, Madden PA, Breslau N, Johnson EO, Hatsukami D, Pomerleau O, Swan GE, Goate AM, Rutter J, Bertelsen S, Fox L, Fugman D, Martin NG, Montgomery GW, Wang JC, Ballinger DG, Rice JP, Bierut LJ. 2007. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet 16: 36-49.
47. Savitz J, Solms M, Ramesar R. 2006. The molecular genetics of cognition: Dopamine, COMT and BDNF. Genes Brain Behav 5: 311-328.
48. Schlaepfer IR, Hoft NR, Collins AC, Corley RP, Hewitt JK, Hopfer CJ, Lessem JM, McQueen MB, Rhee SH, Ehringer MA. 2008. The CHRNA5/A3/B4 gene cluster variability as an important determinant of early alcohol and tobacco initiation in young adults. Biol Psychiatry 63: 1039-1046.
49. Sherva R, Wilhelmsen K, Pomerleau CS, Chasse SA, Rice JP, Snedecor SM, Bierut LJ, Neuman RJ, Pomerleau OF. 2008. Association of a single nucleotide polymorphism in neuronal acetylcholine receptor subunit alpha 5 (CHRNA5) with smoking status and with 'pleasurable buzz' during early experimentation with smoking. Addiction 103: 1544-1552.
50. Stevens VL, Bierut LJ, Talbot JT, Wang JC, Sun J, Hinrichs AL, Thun MJ, Goate A, Calle EE. 2008. Nicotinic receptor gene variants influence susceptibility to heavy smoking. Cancer Epidemiol Biomarkers Prev 17: 3517-3525.
51. Stolerman IP, Naylor CG, Mesdaghinia A, Morris HV. 2009. The duration of nicotine-induced attentional enhancement in the five-choice serial reaction time task: Lack of long-lasting cognitive improvement. Behav Pharmacol 20(8): 742-754.
52. Sullivan P, Kendler K. 1999. The genetic epidemiology of smoking. Nicotine Tob Res 1 (Suppl.): 51-57.
53. Tewes U. 1991. HAWIE-R Hamburg-Wechsler Intelligenztest für Erwachsene. Revision 1991. Hogrefe: Goettingen.
54. The Tobacco and Genetics Consortium. 2010. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet 42: 441-447.
55. Thiel CM, Zilles K, Fink GR. 2005. Nicotine modulates reorienting of visuospatial attention and neural activity in human parietal cortex. Neuropsychopharmacology 30: 810-820.
56. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, Manolescu A, Thorleifsson G, Stefansson H, Ingason A, Stacey SN, Bergthorsson JT, Thorlacius S, Gudmundsson J, Jonsson T, Jakobsdottir M, Saemundsdottir J, Olafsdottir O, Gudmundsson LJ, Bjornsdottir G, Kristjansson K, Skuladottir H, Isaksson HJ, Gudbjartsson T, Jones GT, Mueller T, Gottsäter A, Flex A, Aben KK, de Vegt F, Mulders PF, Isla D, Vidal MJ, Asin L, Saez B, Murillo L, Blondal T, Kolbeinsson H, Stefansson JG, Hansdottir I, Runarsdottir V, Pola R, Lindblad B, van Rij AM, Dieplinger B, Haltmayer M, Mayordomo JI, Kiemeney LA, Matthiasson SE, Oskarsson H, Tyrfingsson T, Gudbjartsson DF, Gulcher JR, Jonsson S, Thorsteinsdottir U, Kong A, Stefansson K. 2008. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452: 638-642.
57. Thorgeirsson TE, Gudbjartsson DF, Surakka I, Vink JM, Amin N, Geller F, Sulem P, Rafnar T, Esko T, Walter S, Gieger C, Rawal R, Mangino M, Prokopenko I, Mägi R, Keskitalo K, Gudjonsdottir IH, Gretarsdottir S, Stefansson H, Thompson JR, Aulchenko YS, Nelis M, Aben KK, den Heijer M, Dirksen A, Ashraf H, Soranzo N, Valdes AM, Steves C, Uitterlinden AG, Hofman A, Tönjes A, Kovacs P, Hottenga JJ, Willemsen G, Vogelzangs N, Döring A, Dahmen N, Nitz B, Pergadia ML, Saez B, De Diego V, Lezcano V, Garcia-Prats MD, Ripatti S, Perola M, Kettunen J, Hartikainen AL, Pouta A, Laitinen J, Isohanni M, Huei-Yi S, Allen M, Krestyaninova M, Hall AS, Jones GT, van Rij AM, Mueller T, Dieplinger B, Haltmayer M, Jonsson S, Matthiasson SE, Oskarsson H, Tyrfingsson T, Kiemeney LA, Mayordomo JI, Lindholt JS, Pedersen JH, Franklin WA, Wolf H, Montgomery GW, Heath AC, Martin NG, Madden PA, Giegling I, Rujescu D, Järvelin MR, Salomaa V, Stumvoll M, Spector TD, Wichmann HE, Metspalu A, Samani NJ, Penninx BW, Oostra BA, Boomsma DI, Tiemeier H, van Duijn CM, Kaprio J, Gulcher JR, ENGAGE Consortium, McCarthy MI, Peltonen L, Thorsteinsdottir U, Stefansson K, 2010. Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet 42: 448-453.
58. Wang JC, Cruchaga C, Saccone NL, Bertelsen S, Liu P, Budde JP, Duan W, Fox L, Grucza RA, Kern J, Mayo K, Reyes O, Rice J, Saccone SF, Spiegel N, Steinbach JH, Stitzel JA, Anderson MW, You M, Stevens VL, Bierut LJ, Goate AM, COGEND collaborators and GELCC collaborators, 2009. Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5. Hum Mol Genet 18: 3125-3135.
59. Weiss RB, Baker TB, Cannon DS, von Niederhausern A, Dunn DM, Matsunami N, Singh NA, Baird L, Coon H, McMahon WM, Piper ME, Fiore MC, Scholand MB, Connett JE, Kanner RE, Gahring LC, Rogers SW, Hoidal JR, Leppert MF. 2008. A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genet 4: e1000125.
60. Winterer G, Goldman D. 2003. Genetics of human prefrontal function. Brain Res Brain Res Rev 43: 134-163.
61. Winterer G, Musso F, Vucurevic G, Stoeter P, Konrad A, Seker B, Gallinat J, Dahmen N, Weinberger DR. 2006. COMT genotype predicts BOLD signal and noise characteristics in prefrontal circuits. Neuroimage 32: 1722-1732.
62. Winterer G, Musso F, Konrad A, Vucurevic G, Stoeter P, Sander T, Gallinat J. 2007. Association of attentional network function with exon 5 variations of the CHRNA4 gene. Hum Mol Genet 16: 2165-2174.
63. Yakir A, Rigbi A, Kanyas K, Pollak Y, Kahana G, Karni O, Eitan R, Kertzman S, Lerer B. 2007. Why do young women smoke? III. Attention and impulsivity as neurocognitive predisposing factors. Eur Neuropsychopharmacol 17: 339-351.
64. Young TL, Rogers KD. 1986. School performance characteristics preceding onset of smoking in high school students. Am J Dis Child 140: 257-259.